BioStock studio: Saniona celebrates a decade of progress
Today marks Saniona’s 10th anniversary since its founding. BioStock was visited in the studio by the company’s founder Jørgen Drejer, now Chief Scientific Officer, who talks about the transformation that the company has undergone during this decade. We also learn more about the success of the primary drug candidate Tesomet, the importance of now having a US-based management team and his view of the company’s future.
Watch the interview with Jørgen Drejer at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se